Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (31-40 of 459) with videos related to

Pageof 46
Sort By:
Expert Review of Gastroenterology & Hepatology|June 25, 2021
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Journal of Clinical Medicine|November 11, 2022
Cancer Immunotherapy: Harnessing the Immune System to Fight CancerAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Nature Reviews. Urology|May 3, 2024
The evolving treatment landscape of metastatic urothelial cancerGiandomenico Roviello, Matteo Santoni, Guru P Sonpavde, et al.
Carcinogenesis|October 20, 2012
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agentsMassimo Nabissi, Maria Beatrice Morelli, Matteo Santoni, et al.
European Urology|November 15, 2025
Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. Pembrolizumab plus Platinum-based Chemotherapy for Patients with Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.3266Fernando Sabino Marques Monteiro, Matteo Santoni, Philippe E Spiess
European Urology|August 13, 2025
Re: First-line Therapy for Advanced Non-Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysisFrancesco Massari, Matteo Rosellini, Andrea Marchetti, et al.
Journal of Clinical Medicine|February 25, 2022
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-AnalysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
European Urology|May 12, 2023
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital TumoursValentina Tateo, Veronica Mollica, Alessandro Rizzo, et al.
Frontiers in Oncology|May 28, 2021
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer EnvironmentsMatteo Santoni, Francesco Tombesi, Alessia Cimadamore, et al.
Annals of Translational Medicine|October 3, 2019
Key players of neuroendocrine differentiation in prostate cancerMatteo Santoni, Gaetano Aurilio, Alessandro Maccioni, et al.
Pageof 46

Showing results (31-40 of 459) with videos related to

Sort By:
Pageof 46
Expert Review of Gastroenterology & Hepatology|June 25, 2021
Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Journal of Clinical Medicine|November 11, 2022
Cancer Immunotherapy: Harnessing the Immune System to Fight CancerAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Nature Reviews. Urology|May 3, 2024
The evolving treatment landscape of metastatic urothelial cancerGiandomenico Roviello, Matteo Santoni, Guru P Sonpavde, et al.
Carcinogenesis|October 20, 2012
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agentsMassimo Nabissi, Maria Beatrice Morelli, Matteo Santoni, et al.
European Urology|November 15, 2025
Re: Fernando Cotait Maluf, Karine Trindade, Daniel Preto, et al. Pembrolizumab plus Platinum-based Chemotherapy for Patients with Advanced Penile Cancer: The Nonrandomized HERCULES (LACOG 0218) Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.3266Fernando Sabino Marques Monteiro, Matteo Santoni, Philippe E Spiess
European Urology|August 13, 2025
Re: First-line Therapy for Advanced Non-Clear Cell Renal Cell Carcinoma. A Systematic Review and Meta-analysisFrancesco Massari, Matteo Rosellini, Andrea Marchetti, et al.
Journal of Clinical Medicine|February 25, 2022
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-AnalysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
European Urology|May 12, 2023
Re: WHO Classification of Tumours, 5th Edition, Volume 8: Urinary and Male Genital TumoursValentina Tateo, Veronica Mollica, Alessandro Rizzo, et al.
Frontiers in Oncology|May 28, 2021
Conceptual Analogies Between Multi-Scale Feeding and Feedback Cycles in Supermassive Black Hole and Cancer EnvironmentsMatteo Santoni, Francesco Tombesi, Alessia Cimadamore, et al.
Annals of Translational Medicine|October 3, 2019
Key players of neuroendocrine differentiation in prostate cancerMatteo Santoni, Gaetano Aurilio, Alessandro Maccioni, et al.
Pageof 46